TY - JOUR
T1 - Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies
AU - Regeneron Genetics Center
AU - Cavazos, Taylor B.
AU - Kachuri, Linda
AU - Graff, Rebecca E.
AU - Nierenberg, Jovia L.
AU - Thai, Khanh K.
AU - Alexeeff, Stacey
AU - Van Den Eeden, Stephen
AU - Corley, Douglas A.
AU - Kushi, Lawrence H.
AU - Hoffmann, Thomas J.
AU - Ziv, Elad
AU - Habel, Laurel A.
AU - Jorgenson, Eric
AU - Sakoda, Lori C.
AU - Witte, John S.
AU - Abecasis, Goncalo
AU - Baras, Aris
AU - Cantor, Michael
AU - Coppola, Giovanni
AU - Deubler, Andrew
AU - Economides, Aris
AU - Karalis, Katia
AU - Lotta, Luca A.
AU - Overton, John D.
AU - Reid, Jeffrey G.
AU - Siminovitch, Katherine
AU - Shuldiner, Alan
AU - Beechert, Christina
AU - Forsythe, Caitlin
AU - Fuller, Erin D.
AU - Gu, Zhenhua
AU - Lattari, Michael
AU - Lopez, Alexander
AU - Padilla, Maria Sotiropoulos
AU - Pradhan, Manasi
AU - Manoochehri, Kia
AU - Schleicher, Thomas D.
AU - Widom, Louis
AU - Wolf, Sarah E.
AU - Ulloa, Ricardo H.
AU - Averitt, Amelia
AU - Banerjee, Nilanjana
AU - Li, Dadong
AU - Malhotra, Sameer
AU - Sharma, Deepika
AU - Staples, Jeffrey
AU - Bai, Xiaodong
AU - Balasubramanian, Suganthi
AU - Bao, Suying
AU - Boutkov, Boris
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/12
Y1 - 2022/12
N2 - Background: Up to one of every six individuals diagnosed with one cancer will be diagnosed with a second primary cancer in their lifetime. Genetic factors contributing to the development of multiple primary cancers, beyond known cancer syndromes, have been underexplored. Methods: To characterize genetic susceptibility to multiple cancers, we conducted a pan-cancer, whole-exome sequencing study of individuals drawn from two large multi-ancestry populations (6429 cases, 165,853 controls). We created two groupings of individuals diagnosed with multiple primary cancers: (1) an overall combined set with at least two cancers across any of 36 organ sites and (2) cancer-specific sets defined by an index cancer at one of 16 organ sites with at least 50 cases from each study population. We then investigated whether variants identified from exome sequencing were associated with these sets of multiple cancer cases in comparison to individuals with one and, separately, no cancers. Results: We identified 22 variant-phenotype associations, 10 of which have not been previously discovered and were significantly overrepresented among individuals with multiple cancers, compared to those with a single cancer. Conclusions: Overall, we describe variants and genes that may play a fundamental role in the development of multiple primary cancers and improve our understanding of shared mechanisms underlying carcinogenesis.
AB - Background: Up to one of every six individuals diagnosed with one cancer will be diagnosed with a second primary cancer in their lifetime. Genetic factors contributing to the development of multiple primary cancers, beyond known cancer syndromes, have been underexplored. Methods: To characterize genetic susceptibility to multiple cancers, we conducted a pan-cancer, whole-exome sequencing study of individuals drawn from two large multi-ancestry populations (6429 cases, 165,853 controls). We created two groupings of individuals diagnosed with multiple primary cancers: (1) an overall combined set with at least two cancers across any of 36 organ sites and (2) cancer-specific sets defined by an index cancer at one of 16 organ sites with at least 50 cases from each study population. We then investigated whether variants identified from exome sequencing were associated with these sets of multiple cancer cases in comparison to individuals with one and, separately, no cancers. Results: We identified 22 variant-phenotype associations, 10 of which have not been previously discovered and were significantly overrepresented among individuals with multiple cancers, compared to those with a single cancer. Conclusions: Overall, we describe variants and genes that may play a fundamental role in the development of multiple primary cancers and improve our understanding of shared mechanisms underlying carcinogenesis.
KW - Germline genetics
KW - Multiple primary cancers
KW - Pleiotropy
KW - Whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85139351377&partnerID=8YFLogxK
U2 - 10.1186/s12916-022-02535-6
DO - 10.1186/s12916-022-02535-6
M3 - Article
C2 - 36199081
AN - SCOPUS:85139351377
SN - 1741-7015
VL - 20
JO - BMC Medicine
JF - BMC Medicine
IS - 1
M1 - 332
ER -